絞り込み

16399

広告

Oct parameters as predictive factors for the visual outcome after ranibizumab therapy in neovascular age related macular degeneration.

著者 Valverde-Megías A , Donate-López J , García-Gil-de-Bernabé J , Megías-Fresno A , García-Feijoo J
Arch Soc Esp Oftalmol.2015 Jan 22 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (3,538view , 1users)

Full Text Sources

Medical

Miscellaneous

To evaluate macular morphological parameters measured by spectral domain optical coherence tomography (SD-OCT) as predictive factors of visual outcome in patients with exudative age-related macular degeneration (AMD) treated with ranibizumab.
PMID: 25620678 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード